Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial

PURPOSE: Precision medicine trials constitute a precious source of molecular data with prospective clinical annotations allowing the exploration of patients’ subpopulations according to specific clinical or biological questions. Using the SHIVA01—the first randomized trial comparing molecularly targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Basse, Clémence, Morel, Claire, Callens, Céline, Pierron, Gaëlle, Servois, Vincent, Vincent-Salomon, Anne, Jobard, Aude, Alt, Marie, Ricci, Francesco, Loirat, Delphine, Sablin, Marie-Paule, Bretagne, Marie, Saint-Ghislain, Mathilde, Hescot, Ségolène, Gonçalves, Anthony, Tredan, Olivier, Dubot, Coraline, Gavoille, Céline, Delord, Jean-Pierre, Campone, Mario, Isambert, Nicolas, Belin, Lisa, Bieche, Ivan, Kamal, Maud, Le Tourneau, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450915/
https://www.ncbi.nlm.nih.gov/pubmed/32914004
http://dx.doi.org/10.1200/PO.18.00048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450915/
https://www.ncbi.nlm.nih.gov/pubmed/32914004
http://dx.doi.org/10.1200/PO.18.00048

Ejemplares similares